E-mail

E-mail a Wiley Online Library Link

O. Outteryck, J.C. Ongagna, B. Brochet, L. Rumbach, C. Lebrun-Frenay, M. Debouverie, H. Zéphir, J.C. Ouallet, E. Berger, M. Cohen, S. Pittion, D. Laplaud, S. Wiertlewski, P. Cabre, J. Pelletier, A. Rico, G. Defer, N. Derache, W. Camu, E. Thouvenot, T. Moreau, A. Fromont, A. Tourbah, P. Labauge, G. Castelnovo, P. Clavelou, O. Casez, P. Hautecoeur, C. Papeix, C. Lubetzki, B. Fontaine, N. Couturier, N. Bohossian, M. Clanet, P. Vermersch, J. de Sèze, D. Brassat and on behalf of the BIONAT network, and CFSEP A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort European Journal of Neurology 21

Article first published online: 12 JUN 2013 | DOI: 10.1111/ene.12204

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

Choose captcha format: Image or Audio. Click here if you need help.

SEARCH